Skip to main content

Gout Topic Center

Featured

News
03/13/2025
Anthony Calabro, MA
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with...
03/13/2025
Rheumatology & Arthritis
News
01/17/2022
Investigators call for more high-quality studies to help reduce hospital admissions for gout.
Investigators call for more high-quality studies to help reduce hospital admissions for gout.
Investigators call for more...
01/17/2022
Rheumatology & Arthritis
How Should You Approach This Difficult Gout Management Problem?
Quiz
01/07/2021
Author:  Theodore R. Fields, MD Hospital for Special Surgery Weill Cornell Medical College   A 67-year-old man presents for follow-up of his gout and kidney disease. His mother and brother had...
Author:  Theodore R. Fields, MD Hospital for Special Surgery Weill Cornell Medical College   A 67-year-old man presents for follow-up of his gout and kidney disease. His mother and brother had...
...
01/07/2021
Rheumatology & Arthritis
Why Is This Man’s Toe Painful, Swollen, and Red?
Case Report
01/30/2020
Rheumatology & Arthritis
Poll
10/16/2019
What do you observe as the main reason for nonadherence to urate-lowering therapy among your patients? Patients tend to feel better between flares.Patients are already receiving treatment for comorbidities from...
What do you observe as the main reason for nonadherence to urate-lowering therapy among your patients? Patients tend to feel better between flares.Patients are already receiving treatment for comorbidities from...
What...
10/16/2019
Rheumatology & Arthritis
RHEUMATOLOGY
08/05/2019
Dr Solomon discusses what rheumatologists should know about interleukin-1β inhibitors, his research on the relationship between the inhibitors and gout, and more.
Dr Solomon discusses what rheumatologists should know about interleukin-1β inhibitors, his research on the relationship between the inhibitors and gout, and more.
Dr Solomon discusses what...
08/05/2019
Rheumatology & Arthritis
07/08/2019
More than a quarter of patients with gout are discharged from emergency departments (ED) with opioids, despite the availability of corticosteroids, colchicine, and other indicated treatments, according to a recent...
More than a quarter of patients with gout are discharged from emergency departments (ED) with opioids, despite the availability of corticosteroids, colchicine, and other indicated treatments, according to a recent...
More...
07/08/2019
Rheumatology & Arthritis
07/05/2019
Opioids are often prescribed to individuals with acute gout who are discharged from an emergency department (ED), according to study findings. The researchers evaluated data from the Lifespan electronic health records...
Opioids are often prescribed to individuals with acute gout who are discharged from an emergency department (ED), according to study findings. The researchers evaluated data from the Lifespan electronic health records...
Opioids...
07/05/2019
Rheumatology & Arthritis
Q&As
04/18/2019
Gout is the most common inflammatory arthritis among men and women and can be difficult to treat, according to previous studies. In a new study1, Julianna Desmarais, MD, instructor of medicine in the division of...
Gout is the most common inflammatory arthritis among men and women and can be difficult to treat, according to previous studies. In a new study1, Julianna Desmarais, MD, instructor of medicine in the division of...
Gout is...
04/18/2019
Rheumatology & Arthritis
04/18/2019
Anakinra is a viable alternative to the common therapeutic options of colchicine, naproxen, or prednisone for the treatment of acute gout flares, according to a new study.   To determine anakinra’s efficacy,...
Anakinra is a viable alternative to the common therapeutic options of colchicine, naproxen, or prednisone for the treatment of acute gout flares, according to a new study.   To determine anakinra’s efficacy,...
Anakinra...
04/18/2019
Rheumatology & Arthritis
03/01/2019
Pegloticase treatment can quickly resolve the tophi that many patients with gout experience, according to a new study. The American College of Rheumatology recommends that the target serum urate should be lowered sufficiently in order to...
Pegloticase treatment can quickly resolve the tophi that many patients with gout experience, according to a new study. The American College of Rheumatology recommends that the target serum urate should be lowered sufficiently in order to...
Pegloticase treatment can...
03/01/2019
Rheumatology & Arthritis

Insights

RHEUMATOLOGY
08/05/2019
Dr Solomon discusses what rheumatologists should know about interleukin-1β inhibitors, his research on the relationship between the inhibitors and gout, and more.
Dr Solomon discusses what rheumatologists should know about interleukin-1β inhibitors, his research on the relationship between the inhibitors and gout, and more.
Dr Solomon discusses what...
08/05/2019
Rheumatology & Arthritis
Al Kim
Video
01/31/2025
Dr Kim reviews the the impact of poor sleep and circadian dysfunction on patients with systemic lupus erythematosus.
Dr Kim reviews the the impact of poor sleep and circadian dysfunction on patients with systemic lupus erythematosus.
Dr Kim reviews the the impact of...
01/31/2025
Rheumatology & Arthritis
Len Calabrese
Podcast
01/02/2025
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the...
01/02/2025
Rheumatology & Arthritis
Bryant England
Video
12/06/2024
Dr England recaps his presentation on interstitial lung disease among patients with rheumatoid arthritis, including the importance of early detection and how to diagnose this condition,
Dr England recaps his presentation on interstitial lung disease among patients with rheumatoid arthritis, including the importance of early detection and how to diagnose this condition,
Dr England recaps his...
12/06/2024
Rheumatology & Arthritis
Misti Paudel
Podcast
08/12/2024
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she...
08/12/2024
Rheumatology & Arthritis
Sponsored Video
07/03/2024
Professor Iain McInnes of the University of Glasgow delves into the latest science on the importance of the interleukin-12 interleukin-17 axis in axial spondyloarthritis.
Professor Iain McInnes of the University of Glasgow delves into the latest science on the importance of the interleukin-12 interleukin-17 axis in axial spondyloarthritis.
Professor Iain McInnes of the...
07/03/2024
Rheumatology & Arthritis
Vikas Majithia
Podcast
06/20/2024
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck...
06/20/2024
Rheumatology & Arthritis
Sponsored Video
06/04/2024
The RheuMuseum Lecture Series continues with Professor Iain McInnes taking a deeper dive into the pathogenesis of psoriatic arthritis.
The RheuMuseum Lecture Series continues with Professor Iain McInnes taking a deeper dive into the pathogenesis of psoriatic arthritis.
The RheuMuseum Lecture Series...
06/04/2024
Rheumatology & Arthritis
Sponsored Video
04/30/2024
In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.
In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.
In part 1 of this video series,...
04/30/2024
Rheumatology & Arthritis
Podcast
04/08/2024
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
In this podcast, Drs England and...
04/08/2024
Rheumatology & Arthritis
Dr Shari Lipner
Podcast
03/27/2024
Shari Lipner, MD, PhD
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
In a cross-sectional study of 36...
03/27/2024
Rheumatology & Arthritis

News

News
03/13/2025
Anthony Calabro, MA
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with...
03/13/2025
Rheumatology & Arthritis
News
01/17/2022
Investigators call for more high-quality studies to help reduce hospital admissions for gout.
Investigators call for more high-quality studies to help reduce hospital admissions for gout.
Investigators call for more...
01/17/2022
Rheumatology & Arthritis
News
04/02/2025
Rebecca Mashaw
Investigators set out to determine if methotrexate could help fill the gap in effective treatments for osteoarthritis.
Investigators set out to determine if methotrexate could help fill the gap in effective treatments for osteoarthritis.
Investigators set out to...
04/02/2025
Rheumatology & Arthritis
News
04/01/2025
Jessica Garlewicz
The follow-up study included 153 former BeSt participants (median 20 years post-enrollment) and 282 former IMPROVED participants (median 12 years post-enrollment).
The follow-up study included 153 former BeSt participants (median 20 years post-enrollment) and 282 former IMPROVED participants (median 12 years post-enrollment).
The follow-up study included 153...
04/01/2025
Rheumatology & Arthritis
News
04/01/2025
Jessica Garlewicz
The study included 96,475 person-years of follow-up and identified 1,423 incident cancers.
The study included 96,475 person-years of follow-up and identified 1,423 incident cancers.
The study included 96,475...
04/01/2025
Rheumatology & Arthritis
News
04/01/2025
Jessica Garlewicz
The study followed 611 patients with moderate to severe RA who experienced failure of an initial TNFi.
The study followed 611 patients with moderate to severe RA who experienced failure of an initial TNFi.
The study followed 611 patients...
04/01/2025
Rheumatology & Arthritis
News
03/17/2025
Jessica Garlewicz
Tumor necrosis factor inhibitors provide a protective effect and reduce bone fragility, a new study suggests.
Tumor necrosis factor inhibitors provide a protective effect and reduce bone fragility, a new study suggests.
Tumor necrosis factor inhibitors...
03/17/2025
Rheumatology & Arthritis
News
03/17/2025
Jessica Garlewicz
Primary care is the major bottleneck for patients seeking axSpA care in the UK.
Primary care is the major bottleneck for patients seeking axSpA care in the UK.
Primary care is the major...
03/17/2025
Rheumatology & Arthritis
News
03/14/2025
Rebecca Mashaw
Investigators found some sex-specific differences in incident gout appear to be significantly associated to the type as well as the amount of alcohol consumed .
Investigators found some sex-specific differences in incident gout appear to be significantly associated to the type as well as the amount of alcohol consumed .
Investigators found some...
03/14/2025
Rheumatology & Arthritis
News
03/13/2025
Anthony Calabro, MA
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with...
03/13/2025
Rheumatology & Arthritis
News
03/13/2025
Riya Gandhi, MA
New findings support a tailored approach to treating rheumatoid arthritis with biologic and targeted synthetic DMARDs in clinical practice.
New findings support a tailored approach to treating rheumatoid arthritis with biologic and targeted synthetic DMARDs in clinical practice.
New findings support a tailored...
03/13/2025
Rheumatology & Arthritis
News
03/12/2025
Jessica Garlewicz
Researchers call for focus on improved methodology on spinal ligamentous soft tissue to speed diagnosis of axial psoriatic arthritis.
Researchers call for focus on improved methodology on spinal ligamentous soft tissue to speed diagnosis of axial psoriatic arthritis.
Researchers call for focus on...
03/12/2025
Rheumatology & Arthritis

Interactive Features

News
03/13/2025
Anthony Calabro, MA
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with...
03/13/2025
Rheumatology & Arthritis
News
01/17/2022
Investigators call for more high-quality studies to help reduce hospital admissions for gout.
Investigators call for more high-quality studies to help reduce hospital admissions for gout.
Investigators call for more...
01/17/2022
Rheumatology & Arthritis
How Should You Approach This Difficult Gout Management Problem?
Quiz
01/07/2021
Author:  Theodore R. Fields, MD Hospital for Special Surgery Weill Cornell Medical College   A 67-year-old man presents for follow-up of his gout and kidney disease. His mother and brother had...
Author:  Theodore R. Fields, MD Hospital for Special Surgery Weill Cornell Medical College   A 67-year-old man presents for follow-up of his gout and kidney disease. His mother and brother had...
...
01/07/2021
Rheumatology & Arthritis
Why Is This Man’s Toe Painful, Swollen, and Red?
Case Report
01/30/2020
Rheumatology & Arthritis
Poll
10/16/2019
What do you observe as the main reason for nonadherence to urate-lowering therapy among your patients? Patients tend to feel better between flares.Patients are already receiving treatment for comorbidities from...
What do you observe as the main reason for nonadherence to urate-lowering therapy among your patients? Patients tend to feel better between flares.Patients are already receiving treatment for comorbidities from...
What...
10/16/2019
Rheumatology & Arthritis
RHEUMATOLOGY
08/05/2019
Dr Solomon discusses what rheumatologists should know about interleukin-1β inhibitors, his research on the relationship between the inhibitors and gout, and more.
Dr Solomon discusses what rheumatologists should know about interleukin-1β inhibitors, his research on the relationship between the inhibitors and gout, and more.
Dr Solomon discusses what...
08/05/2019
Rheumatology & Arthritis
07/08/2019
More than a quarter of patients with gout are discharged from emergency departments (ED) with opioids, despite the availability of corticosteroids, colchicine, and other indicated treatments, according to a recent...
More than a quarter of patients with gout are discharged from emergency departments (ED) with opioids, despite the availability of corticosteroids, colchicine, and other indicated treatments, according to a recent...
More...
07/08/2019
Rheumatology & Arthritis
07/05/2019
Opioids are often prescribed to individuals with acute gout who are discharged from an emergency department (ED), according to study findings. The researchers evaluated data from the Lifespan electronic health records...
Opioids are often prescribed to individuals with acute gout who are discharged from an emergency department (ED), according to study findings. The researchers evaluated data from the Lifespan electronic health records...
Opioids...
07/05/2019
Rheumatology & Arthritis
Q&As
04/18/2019
Gout is the most common inflammatory arthritis among men and women and can be difficult to treat, according to previous studies. In a new study1, Julianna Desmarais, MD, instructor of medicine in the division of...
Gout is the most common inflammatory arthritis among men and women and can be difficult to treat, according to previous studies. In a new study1, Julianna Desmarais, MD, instructor of medicine in the division of...
Gout is...
04/18/2019
Rheumatology & Arthritis
04/18/2019
Anakinra is a viable alternative to the common therapeutic options of colchicine, naproxen, or prednisone for the treatment of acute gout flares, according to a new study.   To determine anakinra’s efficacy,...
Anakinra is a viable alternative to the common therapeutic options of colchicine, naproxen, or prednisone for the treatment of acute gout flares, according to a new study.   To determine anakinra’s efficacy,...
Anakinra...
04/18/2019
Rheumatology & Arthritis
News
04/02/2025
Rebecca Mashaw
Investigators set out to determine if methotrexate could help fill the gap in effective treatments for osteoarthritis.
Investigators set out to determine if methotrexate could help fill the gap in effective treatments for osteoarthritis.
Investigators set out to...
04/02/2025
Rheumatology & Arthritis
News
04/01/2025
Jessica Garlewicz
The follow-up study included 153 former BeSt participants (median 20 years post-enrollment) and 282 former IMPROVED participants (median 12 years post-enrollment).
The follow-up study included 153 former BeSt participants (median 20 years post-enrollment) and 282 former IMPROVED participants (median 12 years post-enrollment).
The follow-up study included 153...
04/01/2025
Rheumatology & Arthritis
News
04/01/2025
Jessica Garlewicz
The study included 96,475 person-years of follow-up and identified 1,423 incident cancers.
The study included 96,475 person-years of follow-up and identified 1,423 incident cancers.
The study included 96,475...
04/01/2025
Rheumatology & Arthritis
News
04/01/2025
Jessica Garlewicz
The study followed 611 patients with moderate to severe RA who experienced failure of an initial TNFi.
The study followed 611 patients with moderate to severe RA who experienced failure of an initial TNFi.
The study followed 611 patients...
04/01/2025
Rheumatology & Arthritis
News
03/17/2025
Jessica Garlewicz
Tumor necrosis factor inhibitors provide a protective effect and reduce bone fragility, a new study suggests.
Tumor necrosis factor inhibitors provide a protective effect and reduce bone fragility, a new study suggests.
Tumor necrosis factor inhibitors...
03/17/2025
Rheumatology & Arthritis
News
03/17/2025
Jessica Garlewicz
Primary care is the major bottleneck for patients seeking axSpA care in the UK.
Primary care is the major bottleneck for patients seeking axSpA care in the UK.
Primary care is the major...
03/17/2025
Rheumatology & Arthritis
News
03/17/2025
Jessica Garlewicz
These results emphasize the importance of carefully assessing nonresponse and potentially re-evaluating treatment strategies in patients with persistent symptoms despite biologic or targeted therapy.
These results emphasize the importance of carefully assessing nonresponse and potentially re-evaluating treatment strategies in patients with persistent symptoms despite biologic or targeted therapy.
These results emphasize the...
03/17/2025
Rheumatology & Arthritis
News
03/14/2025
Rebecca Mashaw
Investigators found some sex-specific differences in incident gout appear to be significantly associated to the type as well as the amount of alcohol consumed .
Investigators found some sex-specific differences in incident gout appear to be significantly associated to the type as well as the amount of alcohol consumed .
Investigators found some...
03/14/2025
Rheumatology & Arthritis
News
03/13/2025
Anthony Calabro, MA
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with...
03/13/2025
Rheumatology & Arthritis
News
03/13/2025
Riya Gandhi, MA
New findings support a tailored approach to treating rheumatoid arthritis with biologic and targeted synthetic DMARDs in clinical practice.
New findings support a tailored approach to treating rheumatoid arthritis with biologic and targeted synthetic DMARDs in clinical practice.
New findings support a tailored...
03/13/2025
Rheumatology & Arthritis